GET THE APP

Uremic Cardiomyopathy Open Access Articles | Open Access Journals
Journal of Interventional and General Cardiology

Journal of Interventional and General Cardiology

ISSN: 2684-4591

Open Access

Uremic Cardiomyopathy Open Access Articles

Cardiovascular disease is the leading cause of morbidity and mortality in chronic kidney disease (CKD). Left ventricular hypertrophy (LVH) is the most prevalent cardiac abnormality in these patients and is closely related to mortality. This adverse cardiac fallout is consequence of the underlying CKD-related cardiomyopathy, which has been termed “Uremic Cardiomyopathy”. However, the pathogenesis of uremic cardiomyopathy is multifactorial and is poorly understood.Despite advances in dialysis treatment and in the improved management of hypertension, hypervolemia, anemia, and chronic kidney disease—mineral and bone disorder (CKD-MBD), patients with CKD continue to have abnormal myocardial remodeling, which results in the persistently high rates of cardiovascular events and mortality.In the last two decades, two new components of CKD-MBD have been pinpoint the hormone FGF23, and its cofactor, αKlotho. FGF23 is deleterious to the myocardium, while αKlotho is vigilant. Although αKlotho is an obligatory cofactor for FGF23 action as the underlying phosphaturic hormone in phosphorus homeostasis, the two seem to have independent and antagonistic effects on the myocardium.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Google Scholar citation report
Citations: 11

Journal of Interventional and General Cardiology received 11 citations as per Google Scholar report

Journal of Interventional and General Cardiology peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward